Maryland Oncology Hematology

Introduction

Clinical trials are studies that evaluate the effectiveness of new drugs or treatment strategies. The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. In oncology, clinical trials are especially important because, in the absence of high cure rates, nearly all therapeutic approaches are developmental in nature.  All new cancer drugs that are currently available in the United States were once only available in clinical trials. Patients should decide whether or not participation in a clinical trial is an appropriate treatment option as early in their evaluation as possible because, once treatment of their cancer has been initiated, patients may become ineligible to participate in some clinical trials.

To learn more about Maryland Oncology Hematology’s current clinical trials click here

or contact

Cheryl A. Young, RN, BSN
Clinical Research Coordinator
Office (410) 964-2212 ext 1137
Cheryl.Young@USOncology.com

Next Section: What Are Clinical Trials »